These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 202286)

  • 1. Mode of action of antidepressant drugs.
    Sulser F; Vetulani J; Mobley PL
    Biochem Pharmacol; 1978 Feb; 27(3):257-61. PubMed ID: 202286
    [No Abstract]   [Full Text] [Related]  

  • 2. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 3. Biogenic amines and affective disorders. A critical analysis.
    Luchins D
    Int Pharmacopsychiatry; 1976; 11(3):135-49. PubMed ID: 136425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain.
    Vetulani J; Stawarz RJ; Dingell JV; Sulser F
    Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):109-14. PubMed ID: 183150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some current problems related to the mode of action of antidepressant drugs.
    Carlsson A
    Acta Psychiatr Scand Suppl; 1981; 290():63-6. PubMed ID: 6939325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of antidepressants in use in the United States.
    Richelson E
    J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):4-13. PubMed ID: 7174631
    [No Abstract]   [Full Text] [Related]  

  • 7. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
    Charney DS; Menkes DB; Heninger GR
    Arch Gen Psychiatry; 1981 Oct; 38(10):1160-80. PubMed ID: 6271089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressive agents: classification and mechanism of action].
    Cuenca E; Alamo C; Coullaut-Jáuregui J
    Rev Clin Esp; 1997 Nov; 197 Suppl 3():44-7. PubMed ID: 9477690
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of the beta-adrenergic receptor-adenylate cyclase system following acute and repeated treatment with antidepressants.
    Weiss B; Heydorn W; Frazer A
    Adv Biochem Psychopharmacol; 1982; 31():37-53. PubMed ID: 6282063
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the hypothalamo-pituitary-adrenal axis and the metabolism of serotonin in affective disorders. Therapeutic use of serotonin precursors (review)].
    Pérez de los Cobos Peris J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(3):147-274. PubMed ID: 3526823
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of lithium and antidepressants on electrophysiological and biochemical processes in the CNS.
    Schultz JE; Kopanski C
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():43-54. PubMed ID: 2984891
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of cyclic nucleotides in receptor mechanisms.
    Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S45-6. PubMed ID: 193052
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: implications for the therapy of depression.
    Sulser F; Janowsky AJ; Okada F; Manier DH; Mobley PL
    Neuropharmacology; 1983 Mar; 22(3 Spec No):425-31. PubMed ID: 6304560
    [No Abstract]   [Full Text] [Related]  

  • 15. The nonselective effect of selective antidepressants.
    Montgomery SA
    Adv Biochem Psychopharmacol; 1982; 32():49-55. PubMed ID: 6178265
    [No Abstract]   [Full Text] [Related]  

  • 16. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology.
    Shenker A
    Adv Pediatr; 1992; 39():337-82. PubMed ID: 1359740
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional aspects of the norepinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: molecular approaches to an understanding of affective disorders.
    Sulser F
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jan; 11(1):43-52. PubMed ID: 204950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The noradrenergic cyclic AMP generating system in the rat limbic forebrain and its stereospecificity for butaclamol.
    Robinson SE; Sulser F
    J Pharm Pharmacol; 1976 Aug; 28(8):645-6. PubMed ID: 11316
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypotheses concerning the mechanism of action of antidepressant drugs.
    Maj J; Przegalinski E; Mogilnicka E
    Rev Physiol Biochem Pharmacol; 1984; 100():1-74. PubMed ID: 6146181
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic mechanisms of action of antidepressants.
    Frazer A; Conway P
    Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.